| Literature DB >> 33177600 |
Mahboubeh Pishnamazi1,2,3, Samyar Zabihi4, Pegah Sarafzadeh5, Fatemeh Borousan6,7,8, Azam Marjani9,10, Rasool Pelalak11, Saeed Shirazian3,12.
Abstract
Tolmetin is a non-steroidal anti-inflammatory drug being used to decrease the level of hormones which are the reasons for pain, swelling, tiredness, and stiffness for osteoarthritis and rheumatoid arthritis cases. We evaluated its solubility in supercritical carbon dioxide (SC-CO2) with the aim of drug nanonization, considering temperature and pressure variations between 120 and 400 bar and 308-338 K, in the experiments. In this way, a PVT solubility cell based on static solubility approach coupled with a simple gravimetric procedure was utilized to evaluate the solubility of tolmetin. The solubility values between 5.00 × 10-5 and 2.59 × 10-3 mol fraction were obtained for tolmetin depending on the pressure and temperature of the cell. The measured data demonstrated a direct correlation between pressure and solubility of tolmetin, while the effect of temperature was a dual effect depending on the crossover pressure (160 bar). The calculated solubility data were modeled using several semi-empirical correlations, and the fitting parameters were calculated using the experimental data via appropriate optimization method. The correlated solubility data revealed that the KJ model was the most accurate one with an average absolute relative deviation percent (AARD%) of 6.9. Moreover, the carried out self-consistency analysis utilizing these correlations illustrated great potential of these models to extrapolate the solubility of tolmetin beyond the measured conditions.Entities:
Year: 2020 PMID: 33177600 PMCID: PMC7659337 DOI: 10.1038/s41598-020-76330-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1SC-CO2 drug solubility apparatus[19]. Reprinted from[19], Copyright (2020), with permission from Elsevier.
Figure 2Solubility values of tolmetin.
Solubility of tolmetin.
| P/bar | T/K | |||||||
|---|---|---|---|---|---|---|---|---|
| 308 | 318 | 328 | 338 | |||||
| y | SD | y | SD | y | SD | y | SD | |
| 120 | 1.39 × 10−4 | 1.20 × 10−5 | 8.83 × 10−5 | 5.06 × 10−6 | 6.80 × 10−5 | 1.46 × 10−6 | 5.00 × 10−5 | 2.68 × 10−6 |
| 160 | 2.39 × 10−4 | 1.89 × 10−5 | 2.35 × 10−4 | 1.05 × 10−5 | 1.86 × 10−5 | 5.32 × 10−6 | 1.82 × 10−4 | 4.99 × 10−6 |
| 200 | 2.97 × 10−4 | 1.51 × 10−5 | 3.65 × 10−4 | 2.21 × 10−5 | 4.69 × 10−4 | 3.28 × 10−5 | 4.93 × 10−4 | 2.32 × 10−5 |
| 240 | 3.55 × 10−4 | 1.89 × 10−5 | 4.70 × 10−4 | 2.56 × 10−5 | 6.64 × 10−4 | 4.16 × 10−5 | 8.41 × 10−4 | 5.69 × 10−5 |
| 280 | 4.21 × 10−4 | 2.84 × 10−5 | 6.34 × 10−4 | 4.73 × 10−5 | 8.74 × 10−4 | 6.98 × 10−5 | 1.24 × 10−3 | 7.65 × 10−5 |
| 320 | 4.98 × 10−4 | 2.34 × 10−5 | 7.85 × 10−4 | 5.52 × 10−5 | 1.18 × 10−3 | 1.44 × 10−5 | 1.65 × 10−3 | 1.11 × 10−4 |
| 360 | 5.53 × 10−4 | 4.44 × 10−5 | 9.40 × 10−4 | 6.44 × 10−5 | 1.32 × 10−3 | 7.81 × 10−5 | 2.06 × 10−3 | 1.72 × 10−4 |
| 400 | 6.30 × 10−4 | 5.40 × 10−5 | 1.11 × 10−3 | 7.17 × 10−5 | 1.71 × 10−3 | 1.09 × 10−4 | 2.59 × 10−3 | 2.06 × 10−4 |
Standard uncertainty (u), are u (T) = 0.1 K and u (P) = 0.35 bar.
Fitting parameters of semi-empirical density-based correlations.
| Models (AARD%)a | Mathematical equation of model | Constants | ||
|---|---|---|---|---|
| a | b | c | ||
| Bartle et al. (11.3%) | 25.9 | − 9480 | 0.0122 | |
| Mendez-Santiago-Teja (10.2%) | 12,662- | 27.205 | 3.93 | |
| Kumar and Johnstone (6.9%) | 7.71 | − 7094.4 | 0.361 | |
| Chrastil (12.3%) | − 7149.3 | 24.404 | 7.03 | |
| Garlapati and Madras (12.1%) | − 66.58 | − 5202 | 6.025 | |
aAARD% = 100 × ∑ ((ycalc − yexp)/yexp).
Figure 3Tolmetin solubility results applying, (a) Bartle et al. model, (b) Chrastil, (c) MST and (d) KJ model.
Figure 4Self-consistency test utilizing MST model.